SummerHaven Investment Management LLC Invests $828,000 in Viemed Healthcare, Inc. $VMD

SummerHaven Investment Management LLC purchased a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 121,936 shares of the company’s stock, valued at approximately $828,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. AQR Capital Management LLC acquired a new stake in Viemed Healthcare during the 1st quarter worth approximately $90,000. Jane Street Group LLC purchased a new stake in shares of Viemed Healthcare during the first quarter worth approximately $394,000. Ulland Investment Advisors LLC raised its stake in shares of Viemed Healthcare by 93.8% during the second quarter. Ulland Investment Advisors LLC now owns 30,155 shares of the company’s stock worth $208,000 after purchasing an additional 14,595 shares during the last quarter. Cardinal Point Capital Management ULC acquired a new stake in shares of Viemed Healthcare during the second quarter worth $128,000. Finally, First Eagle Investment Management LLC grew its position in Viemed Healthcare by 7.1% in the 2nd quarter. First Eagle Investment Management LLC now owns 455,344 shares of the company’s stock valued at $3,146,000 after buying an additional 30,000 shares during the last quarter. 74.24% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on VMD. Wall Street Zen cut shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 10th. Zacks Research raised shares of Viemed Healthcare to a “hold” rating in a report on Thursday, January 8th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Viemed Healthcare in a report on Monday, December 29th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Viemed Healthcare Trading Down 0.9%

NASDAQ:VMD opened at $7.38 on Thursday. Viemed Healthcare, Inc. has a 1 year low of $5.93 and a 1 year high of $8.42. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.01 and a current ratio of 1.13. The stock has a fifty day moving average price of $7.19 and a two-hundred day moving average price of $6.88. The stock has a market capitalization of $280.59 million, a price-to-earnings ratio of 22.36 and a beta of 1.25.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.09 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.09. The business had revenue of $71.91 million for the quarter, compared to analysts’ expectations of $72.00 million. Viemed Healthcare had a net margin of 5.34% and a return on equity of 9.95%.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.